Issue 2, a ballot initiative that would require drugs prices be transparent to consumers, is aimed at lowering health care costs. However, an EpiPen ad has misinterpreted the population that Issue 2 benefits, as approximately 70 percent of EpiPen users are privately insured, and Medicaid patients already pay nothing out of pocket